This assay annulled the expression of the oncogene by inserting a fluorescent reporter gene into the BCR/ABL, as displayed in Figure 2 and Table 2, coding sequence to select the edited hematopoietic cells of CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.